While GLP-1 receptor agonists have transformed obesity and type 2 diabetes treatment, current drug discovery increasingly requires insight into the broader signaling landscape that shapes metabolic homeostasis. INDIGO Biosciences offers a comprehensive panel of cell-based reporter assays to interrogate key nuclear receptors, GPCRs, growth factor receptors, cytokine pathways, and transcription factors involved in metabolic regulation. … Continue reading Beyond GLP-1R: Metabolic Pathway Assays